Literature DB >> 20090478

Social challenges of cancer patients with orbitofacial disfigurement.

Alessandro Bonanno1, Bita Esmaeli, Michelle C Fingeret, David V Nelson, Randal S Weber.   

Abstract

PURPOSE: Patients who undergo orbital exenteration often experience social problems because of their facial disfigurement. The authors studied the interaction of cancer patients who had undergone orbital exenteration with family members and friends (primary groups) and with acquaintances and strangers (secondary groups) in small and large groups.
METHODS: In-depth telephone interviews were conducted with 12 patients treated at a cancer center (7 men and 5 women aged 51-81 years) and 12 family members (8 spouses and 4 children or siblings). Three patients had adenoid cystic carcinoma of lacrimal gland, 3 had squamous cell carcinoma of conjunctiva/eyelid, and 1 each had conjunctival melanoma, eyelid sebaceous gland carcinoma, transitional cell carcinoma of lacrimal sac, adenocarcinoma of orbit, neuroendocrine carcinoma of orbit, and basal cell carcinoma of eyelid. Time from orbital exenteration to interview ranged from 8 months to 36 years (median, 44 months).
RESULTS: Two patient groups were identified according to comfort in interactions with acquaintances and strangers. Always comfortable patients were always at ease. Occasionally comfortable patients were at ease in large groups in situations of "benign neglect" and in small groups when they received "sympathy"; were uncomfortable in large and small groups when episodes of "intrusion" occurred; and had mixed responses to benign neglect in small groups and sympathy in large groups. Both patient groups felt comfortable with family members and friends.
CONCLUSIONS: Patients who will undergo orbital exenteration should be warned about possible difficulties with social interactions. Healthcare personnel should be trained to help patients and family members prepare for such difficulties.

Entities:  

Mesh:

Year:  2010        PMID: 20090478     DOI: 10.1097/IOP.0b013e3181b8e646

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  7 in total

1.  Neighborhood deprivation and clinical outcomes among head and neck cancer patients.

Authors:  Lorraine R Reitzel; Nga Nguyen; Mark E Zafereo; Guojun Li; Qingyi Wei; Erich M Sturgis
Journal:  Health Place       Date:  2012-03-14       Impact factor: 4.078

2.  Development of esthetic prosthesis for a patient with severe stigmatizing facial lesions due to cancer: a pilot study.

Authors:  Douglas Jordan-Ribeiro; Laura Machado Lara Carvalho; Raquel Vilela; Dayse Danielle Rocha; Paula Lopes Ruas; Antônio Ferreira Ávila; Denis Vasconcelos Ferreira; Eduardo Mateus Motta Trindade; Paulo Henrique Pimentel Santos; Monica Assunção Costa Lima; Leonel Mendoza; Rudolf Huebner
Journal:  Support Care Cancer       Date:  2018-05-03       Impact factor: 3.603

3.  Interpreting Life Impact Burn Recovery Evaluation Profile Scores for Use by Clinicians, Burn Survivors, and Researchers.

Authors:  Mary D Slavin; Colleen M Ryan; Jeffrey C Schneider; Amy Acton; Flor Amaya; Cayla Saret; Emily Ohrtman; Audrey Wolfe; Pengsheng Ni; Lewis E Kazis
Journal:  J Burn Care Res       Date:  2021-02-03       Impact factor: 1.845

4.  Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma.

Authors:  Bennett Yau-Bun Hong; Joshua R Ford; Isabella C Glitza; Carlos A Torres Cabala; Michael Tetzlaff; Victor G Prieto; Richard Parker; Claire Daniel; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 Jan-Feb 01       Impact factor: 2.011

5.  Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial.

Authors:  Stephen Gichuhi; Ephantus Macharia; Joy Kabiru; Alain M'bongo Zindamoyen; Hilary Rono; Ernest Ollando; Joseph Wachira; Rhoda Munene; John Maina; Timothy Onyuma; Mandeep S Sagoo; Helen A Weiss; Matthew J Burton
Journal:  Lancet Glob Health       Date:  2016-06       Impact factor: 26.763

Review 6.  Prevalence and Severity of Ocular Surface Neoplasia in African Nations and Need for Early Interventions.

Authors:  Jacob W Reynolds; Margaret L Pfeiffer; Omar Ozgur; Bita Esmaeli
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

7.  Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.

Authors:  Jie Yang; Chuandi Zhou; Yefei Wang; Xianqun Fan; Renbing Jia
Journal:  BMC Ophthalmol       Date:  2019-06-08       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.